🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
2/3 of patients discharged from an emergency department after treatment for...
Status
Completed
Location
Columbia University Medical Center
Start Date
2007-03
Trial ID
NCT00449787
Treatments Being Tested
Migraine affects 16% of the world population and is one of the most disabli...
Status
Completed
Location
Danish Headache Center, Glostrup Hospital
Start Date
2015-01
Trial ID
NCT02309606
Treatments Being Tested
Pilot study to compare the efficacy and safety of two strengths of injectio...
Status
Completed
Location
Clinvest
Start Date
2015-09
Trial ID
NCT02571049
Treatments Being Tested
The purpose of this research is to: 1. Compare two study patches having mi...
Status
Completed
Location
Prism Research, LLC
Start Date
2009-12
Trial ID
NCT01381796
Treatments Being Tested
The purpose of this study is to determine the consistency of response for T...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-10
Trial ID
NCT00240630
Treatments Being Tested
This study is being conducted to evaluate the hypothesis that use of Trexim...
Status
Completed
Location
Clinvest
Start Date
2010-09
Trial ID
NCT01090050
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2019-09-24
Trial ID
NCT04197349
Treatments Being Tested
This phase II evaluation of sumatriptan as a treatment for post traumatic h...
Status
Completed
Location
Harborview Medical Center
Start Date
2013-06
Trial ID
NCT01854385
Treatments Being Tested
The study aim at examining whether Sumatriptan changes the plasma values of...
Status
Completed
Location
Danish Headache Center
Start Date
2007-01
Trial ID
NCT00399633
Treatments Being Tested
the trial is a randomized, open label, crossover, single-administration bio...
Status
Unknown
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02954276
Treatments Being Tested